CG Oncology, Inc. Common stockCGONNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+76.5%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+76.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5.5x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$194.81M+68.2%
2024$115.81M+108.1%
2023$55.65M+57.0%
2022$35.44M+54.3%
2021$22.96M-